Fig.7 Relapse-free survival of patients with endometrial cancer treated with metformin plus medroxyprogesterone acetate(MPA) compared with historical controls treated with MPA alone.
From Mitsuhashi et al., modified with permission［28］
Fig.7 Relapse-free survival of patients with endometrial cancer treated with metformin plus medroxyprogesterone acetate(MPA) compared with historical controls treated with MPA alone.
From Mitsuhashi et al., modified with permission［28］